Survival and toxicity outcomes of hypofractionated conformal radiotherapy compared to conventionally fractionated radiotherapy in the treatment of diffuse intrinsic pontine gliomas
- PMID: 39774994
- DOI: 10.1007/s00381-024-06700-5
Survival and toxicity outcomes of hypofractionated conformal radiotherapy compared to conventionally fractionated radiotherapy in the treatment of diffuse intrinsic pontine gliomas
Abstract
Introduction: Diffuse intrinsic pontine gliomas are associated with dismal survival outcomes. Conventional fractionation radiation to a dose of 60 Gy is the standard of treatment. This retrospective review aims to compare survival and toxicity outcomes of patients treated with conventional fractionation (CF) and hypofractionation (HF) radiotherapy.
Materials and methods: Treatment-naïve diffuse intrinsic pontine glioma patients undergoing radical radiation were analyzed. CF was delivered to a dose of 50-60 Gy in 25-30 fractions, while HF was delivered as 38-40 Gy in 12-15 fractions. All patients were planned via the volumetric modulated arc therapy (VMAT) technique.
Results: A total of 64 patients were eligible for analysis. The median age of presentation was 10 years. Motor deficit was the most common presenting complaint in 51.6% of the patients, with a median symptom duration of 2 months. The pons was the most frequent site of disease epicenter in 71.8% of the patients. After a median follow-up of 9.45 months (range 0.23-72.63 months), 23 patients died, and 28 patients experienced disease progression. The unadjusted hazard ratio (HR) for death in patients treated with HF as compared to CF was 1.330 (95% CI 0.522-3.386) (p-value 0.550, by Cox regression analysis). The median OS for the entire cohort was 13.9 months, while it was 9.7 months (95% CI 5.65-13.74) and 15.1 months (95% CI 9.02-21.18) (p-value = 0.547) with CF and HF, respectively. On multivariate analysis, disease epicenter in the pons was the only significant factor associated with PFS. Hypofractionation was associated with a significantly higher aspiration rate and Ryle's tube requirement (p-value 0.027).
Conclusion: Hypofractionated radiation can be considered for diffuse intrinsic pontine glioma with optimum supportive care.
Keywords: Compliance; Conformal; Conventional; Hypofractionated; Radiotherapy; diffuse intrinsic pontine glioma.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: The work was done in accordance with the Declaration of Helsinki and was approved by institute ethics committee. Competing interests: The authors declare no competing interests.
Similar articles
-
Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.Radiother Oncol. 2014 Apr;111(1):35-40. doi: 10.1016/j.radonc.2014.01.013. Epub 2014 Feb 20. Radiother Oncol. 2014. PMID: 24560760 Clinical Trial.
-
Hypofractionated Radiation Therapy For Diffuse Intrinsic Pontine Glioma: A Noninferiority Randomized Study Including 253 Children.Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):360-368. doi: 10.1016/j.ijrobp.2022.01.054. Epub 2022 Feb 10. Int J Radiat Oncol Biol Phys. 2022. PMID: 35150788 Clinical Trial.
-
Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.J Neurooncol. 2020 Mar;147(1):195-203. doi: 10.1007/s11060-020-03415-w. Epub 2020 Feb 3. J Neurooncol. 2020. PMID: 32016716 Free PMC article.
-
Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis.Medicine (Baltimore). 2020 Oct 16;99(42):e22721. doi: 10.1097/MD.0000000000022721. Medicine (Baltimore). 2020. PMID: 33080729 Free PMC article.
-
External beam radiation dose escalation for high grade glioma.Cochrane Database Syst Rev. 2020 May 21;5(5):CD011475. doi: 10.1002/14651858.CD011475.pub3. Cochrane Database Syst Rev. 2020. PMID: 32437039 Free PMC article.
References
-
- Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43(5):959–64 - DOI - PubMed
-
- Vanan MI, Mehta V, Eisenstat DD (2015) Diffuse intrinsic pontine glioma. Pediatr Neuro-Oncol 117–26
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous